lifestyle.thedishh.com

Author: Revalesio Corporation

Revalesio to Present Advances in Stroke Treatment with RNS60 at the American Society for Experimental Neurotherapeutics (ASENT) Annual Meeting

March 5, 2026
Revalesio to Present Findings from a Post-Hoc Analysis of Phase 2 RESCUE Trial at SVIN 2025, Highlighting RNS60’s Potential to Shorten Hospital Stay

November 21, 2025
Revalesio to Present RNS60 <12-Hour Data from the Phase 2 RESCUE Trial in Acute Ischemic Stroke at World Stroke Congress 2025

October 22, 2025